Panbela Therapeutics Inc (PBLA) - News Archive

In a significant stride towards addressing an urgent unmet medical need, Panbela Therapeutics, Inc. (OTCQB: PBLA) has announced the enrollment of the first patient in its Phase I dose escalation study aimed at treating...

Panbela Therapeutics, Inc., a clinical-stage biopharmaceutical company dedicated to developing groundbreaking therapeutics for patients with urgent unmet medical needs, recently announced the favorable outcome of the th...

Panbela Therapeutics, a clinical stage biopharmaceutical company, has made significant strides in developing disruptive therapeutics for patients with urgent unmet medical needs. Their latest achievement involves the ev...

Panbela Therapeutics, Inc. (OTCQB: PBLA), a renowned clinical stage biopharmaceutical company, is making significant strides in the field of cancer treatment. The company recently announced the issuance of a new patent...

Panbela Therapeutics, Inc. (Panbela), a clinical stage company focused on developing transformative therapeutics for patients facing urgent unmet medical needs, has announced its plans to host a conference call on May 1...

Eflornithine (DFMO): A Promising Breakthrough in Cancer Treatment to be Presented at Digestive Disease Week ConferenceMinneapolis, April 30, 2024 - Panbela Therapeutics, Inc. (OTCQB: PBLA), a clinical stage biopharmaceu...

- An Unprecedented Pivotal Turn in Panbela’s Clinical Trials -In a recent development for clinical-stage pharmaceutical company, Panbela Therapeutics, Inc., the interim data analysis regarding its ASPIRE trial has been...

Panbela Therapeutics, a clinical stage biopharmaceutical company focused on developing innovative therapies to address urgent unmet medical needs, has announced that it will be hosting a conference call on March 26, 202...